A startup in Spain that can log an extraordinary job
INBRAIN Neuroelectronics, an innovative company specializing in BCI therapies, which now has a history of implanting its technology in the human patient for the first time, the procedure carried out at the Salford Royal Hospital in Manchester, once again marks the first time that a graphene cortical interface is It is used in human brain tumor resection surgery, but what is most impressive is that this technology can distinguish at a precise and microscopic level the difference between healthy and cancerous brain tissue, a true revolution in the field of neurosurgery.
Carolina Aguilar, executive director and co-funder of INBRAIN Neuroelectronics described the event as a transformative hit, this impressive story and after years of tests and development, in July 2024 inbrain announced the beginning of the tests in humans, with the aim of evaluating the safety of graphene in direct contact with the brain, it was informed that between 8 to 10 patients would undergo some of these procedures and the study also sought to demonstrate that graphene is superior to other materials in the decoding of brain activities.
But because graphene is so special.
This material is composed of a single head of carbon atoms and its properties are simply extraordinary, it is incredibly thin and light but at the same time extremely resistant, its electrical and mechanical characteristics make it the ideal material for neuronal interfaces, according to the neurocirujan responsible for the Dr David Cop's procedure Graphene allows for much greater signal fidelity than traditional materials, which is essential for performing high-precision surgeries, preserving the patient's vital functions such as movement and speech.
INBRAIN Neuroelectronics technology goes further than precision surgeries, the company has developed a BCI platform that uses graphene to record brain signals in high resolution and offers an adaptive neuroelectronics therapy, which means that the device is capable of distinguishing brain biomarkers , specific safeguards for brain activity that can help you diagnose, monitor and verify these neurological conditions.
With this platform, investigators can also stimulate specific regions of the brain in an extremely precise manner, which opens up a huge gap in therapeutic possibilities, such as the rebalancing of neuronal redactions essential for treating illnesses such as Parkinson's, which affects thousands of people around the world.
In the world of brain interfaces, various computer companies are following the development of this revolutionary technology, including Elon Musk's famous Neuralink, in recent years we have seen incredible advances of the BCI in the medical area allowing for more precise diagnostics hasta communication for people with wireless communication and the control of robotic devices through the interpretation of brain signals.
We are ahead of a future where technology and medicine come together in previously unimaginable forms, brain-computer interfaces like INBRAIN can change the lives of thousands of people, bringing new hope to those suffering from neurological illnesses and starting the journey with a medicine every time More precise and personalized.